Zoek een klinische studie of trial
Andere zoekoptie(s)
8 Resultaat/Resultaten
Aanwerving proef
= 
; Lopend onderzoek
= 
; Gefinancierd door een IRDiRC-lid = 
; Member of a ERN = 
Nationale klinische studie(s)
DUITSLAND
Berlin
ADDRESS: NOT PROVIDED - DE
Safety of Abatacept in patients with interstitial lung disease and common variable immunodeficiency (CVID) and related disease
Institution: Information not provided - DE
DUITSLAND
Nordrhein-Westfalen
KÖLN
BETTER-B: An international, multicentre, randomised controlled pragmatic trial of mirtazapine to alleviate breathlessness in palliative and end of life care - DE
Universitätsklinikum Köln
Zentrum für Palliativmedizin
IERLAND
County Dublin
DUBLIN
BETTER-B: An international, multicentre, randomised controlled pragmatic trial of mirtazapine to alleviate breathlessness in palliative and end of life care - IE
University College Dublin
UCD School of Medicine
ITALIË
EMILIA ROMAGNA
ADDRESS: NOT PROVIDED - IT
BETTER-B: An international, multicentre, randomised controlled pragmatic trial of mirtazapine to alleviate breathlessness in palliative and end of life care - IT
Institution: Information not provided - IT
VERENIGD KONINKRIJK
Cambridgeshire
CAMBRIDGE
APRIL: Safety of Abatacept in Rheumatoid Arthritis Associated Interstitial Lung Disease (a feasibility trial)
Addenbrooke's Hospital
Addenbrookes Hospital
VERENIGD KONINKRIJK
Greater London
LONDON
RBHIPF004 - A randomized, double blind controlled trial comparing rituximab against intravenous cyclophosphamide in connective tissue disease associated interstitial lung disease
National Heart and Lung Institute, Imperial College, Royal Brompton Campus
Interstitial Lung Disease Unit
Multinationale klinische studie(s)
VERENIGD KONINKRIJK
Greater London
LONDON
BETTER-B: An international, multicentre, randomised controlled pragmatic trial of mirtazapine to alleviate breathlessness in palliative and end of life care.
King's College London
King's College London Headquarters
ZWITSERLAND
Suisse Alémanique
BASEL